FDA Inspection 1217797 — Pooja Ghatalia, MD

Pooja Ghatalia, MD — FEI 3027696597

The FDA completed an inspection of Pooja Ghatalia, MD on Sep 11, 2023 in Philadelphia, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Sep 11, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Philadelphia, PA (United States)

Additional details

Clinical Investigator (CI)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.